<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="3.0" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id>
      <journal-id journal-id-type="publisher-id">plos</journal-id>
      <journal-id journal-id-type="pmc">plosone</journal-id>
      <journal-title-group>
        <journal-title>PLoS ONE</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1932-6203</issn>
      <publisher>
        <publisher-name>Public Library of Science</publisher-name>
        <publisher-loc>San Francisco, USA</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="publisher-id">PONE-D-12-03877</article-id>
      <article-id pub-id-type="doi">10.1371/journal.pone.0059064</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Biology</subject>
          <subj-group>
            <subject>Genetics</subject>
            <subj-group>
              <subject>Epigenetics</subject>
              <subj-group>
                <subject>DNA modification</subject>
              </subj-group>
            </subj-group>
            <subj-group>
              <subject>Molecular genetics</subject>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline-v2">
          <subject>Medicine</subject>
          <subj-group>
            <subject>Clinical research design</subject>
            <subj-group>
              <subject>Meta-analyses</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Epidemiology</subject>
            <subj-group>
              <subject>Molecular epidemiology</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Gastroenterology and hepatology</subject>
            <subj-group>
              <subject>Gastrointestinal cancers</subject>
            </subj-group>
          </subj-group>
          <subj-group>
            <subject>Oncology</subject>
            <subj-group>
              <subject>Cancer detection and diagnosis</subject>
              <subj-group>
                <subject>Early detection</subject>
              </subj-group>
            </subj-group>
          </subj-group>
        </subj-group>
        <subj-group subj-group-type="Discipline">
          <subject>Genetics and Genomics</subject>
          <subject>Public Health and Epidemiology</subject>
          <subject>Oncology</subject>
          <subject>Gastroenterology and Hepatology</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title><italic>MLH1</italic> Promoter Methylation Frequency in Colorectal Cancer Patients and Related Clinicopathological and Molecular Features</article-title>
        <alt-title alt-title-type="running-head"><italic>MLH1</italic> Methylation in Colorectal Cancers</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Li</surname>
            <given-names>Xia</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Yao</surname>
            <given-names>Xiaoping</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Yibaina</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Hu</surname>
            <given-names>Fulan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Fan</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Jiang</surname>
            <given-names>Liying</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Liu</surname>
            <given-names>Yupeng</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Wang</surname>
            <given-names>Da</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">
            <sup>2</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Sun</surname>
            <given-names>Guizhi</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">
            <sup>3</sup>
          </xref>
        </contrib>
        <contrib contrib-type="author" xlink:type="simple">
          <name name-style="western">
            <surname>Zhao</surname>
            <given-names>Yashuang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">
            <sup>1</sup>
          </xref>
          <xref ref-type="corresp" rid="cor1">
            <sup>*</sup>
          </xref>
        </contrib>
      </contrib-group>
      <aff id="aff1">
        <label>1</label>
        <addr-line>Department of Epidemiology, Public Health College, Harbin Medical University, Harbin, Heilongjiang Province, P.R. China</addr-line>
      </aff>
      <aff id="aff2">
        <label>2</label>
        <addr-line>Department of Science and Technology Administration, Harbin Medical University, Harbin, Heilongjiang Province, P.R. China</addr-line>
      </aff>
      <aff id="aff3">
        <label>3</label>
        <addr-line>Department of Surgery, Cancer Hospital of Harbin Medical University, Harbin, Heilongjiang Province, P.R. China</addr-line>
      </aff>
      <contrib-group>
        <contrib contrib-type="editor" xlink:type="simple">
          <name name-style="western">
            <surname>Lo</surname>
            <given-names>Anthony WI.</given-names>
          </name>
          <role>Editor</role>
          <xref ref-type="aff" rid="edit1"/>
        </contrib>
      </contrib-group>
      <aff id="edit1">
        <addr-line>The Chinese University of Hong Kong, Hong Kong</addr-line>
      </aff>
      <author-notes>
        <corresp id="cor1">* E-mail: <email xlink:type="simple">zhao_yashuang@263.net</email></corresp>
        <fn fn-type="conflict">
          <p>The authors have declared that no competing interests exist.</p>
        </fn>
        <fn fn-type="con">
          <p>Revised the paper: YZ. Conceived and designed the experiments: YZ. Performed the experiments: XL XY YW. Analyzed the data: FW LJ YL. Contributed reagents/materials/analysis tools: GS DW. Wrote the paper: XL FH YZ.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2013</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>29</day>
        <month>3</month>
        <year>2013</year>
      </pub-date>
      <volume>8</volume>
      <issue>3</issue>
      <elocation-id>e59064</elocation-id>
      <history>
        <date date-type="received">
          <day>7</day>
          <month>2</month>
          <year>2012</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>2</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-year>2013</copyright-year>
        <copyright-holder>Li et al</copyright-holder>
        <license xlink:type="simple">
          <license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p>To describe the frequency of <italic>MLH1</italic> promoter methylation in colorectal cancer (CRC); to explore the associations between <italic>MLH1</italic> promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis.</p>
        </sec>
        <sec>
          <title>Methods</title>
          <p>A literature search of the PubMed and Embase databases was conducted to identify relevant articles published up to September 7, 2012 that described the frequency of <italic>MLH1</italic> promoter methylation or its associations with clinicopathological and molecular factors in CRC. The pooled frequency, odds ratio (OR) and 95% confidence intervals (95% CI) were calculated.</p>
        </sec>
        <sec>
          <title>Results</title>
          <p>The pooled frequency of <italic>MLH1</italic> promoter methylation in unselected CRC was 20.3% (95% CI: 16.8–24.1%). They were 18.7% (95% CI: 14.7–23.6%) and 16.4% (95% CI: 11.9–22.0%) in sporadic and Lynch syndrome (LS) CRC, respectively. Significant associations were observed between <italic>MLH1</italic> promoter methylation and gender (pooled OR = 1.641, 95% CI: 1.215–2.215; <italic>P</italic> = 0.001), tumor location (pooled OR = 3.804, 95% CI: 2.715–5.329; <italic>P</italic>&lt;0.001), tumor differentiation (pooled OR = 2.131, 95% CI: 1.464–3.102; <italic>P</italic>&lt;0.001), MSI (OR: 27.096, 95% CI: 13.717–53.526; <italic>P</italic>&lt;0.001). Significant associations were also observed between <italic>MLH1</italic> promoter methylation and <italic>MLH1</italic> protein expression, <italic>BRAF</italic> mutation (OR = 14.919 (95% CI: 6.427–34.631; <italic>P</italic>&lt;0.001) and 9.419 (95% CI: 2.613–33.953; <italic>P</italic> = 0.001), respectively).</p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p>The frequency of <italic>MLH1</italic> promoter methylation in unselected CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively. <italic>MLH1</italic> promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, <italic>MLH1</italic> protein expression, and <italic>BRAF</italic> mutation.</p>
        </sec>
      </abstract>
      <funding-group>
        <funding-statement>This study was supported by grants from National Natural Science Foundation of China for Priority Areas (NSFC 30972538), Education Bureau of Heilongjiang Province (11531100), and the Graduate Foundation, supported by the Scientific Research of Heilongjiang Province (YJSCX2009-224HLJ) and Harbin Medical University (HCXB2009009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
      </funding-group>
      <counts>
        <page-count count="9"/>
      </counts>
    </article-meta>
  </front>
  <body>
    <sec id="s1">
      <title>Introduction</title>
      <p>Colorectal cancer (CRC) is one of the most common malignancies, representing the third most common cancer in men and the second in women worldwide <xref ref-type="bibr" rid="pone.0059064-GLOBOCAN1">[1]</xref>. One of the genetic pathways in the development of CRC is the microsatellite instability (MSI) <xref ref-type="bibr" rid="pone.0059064-Lengauer1">[2]</xref>.</p>
      <p>Microsatellites are repeated DNA sequences which occur approximately every 50–100 Kb base pairs throughout the human genome <xref ref-type="bibr" rid="pone.0059064-Thibodeau1">[3]</xref>, <xref ref-type="bibr" rid="pone.0059064-Ionov1">[4]</xref>. Multiple studies have indicated that about 90% of the Lynch Syndrome (LS) <xref ref-type="bibr" rid="pone.0059064-Aaltonen1">[5]</xref>, <xref ref-type="bibr" rid="pone.0059064-Tannergard1">[6]</xref> and 10% to 15% of sporadic CRC can be detected of MSI <xref ref-type="bibr" rid="pone.0059064-Thibodeau1">[3]</xref>, <xref ref-type="bibr" rid="pone.0059064-Ionov1">[4]</xref>. MSI in LS and sporadic CRC occurs through two different mechanisms. In LS, MSI is mainly caused by germline mutation of mismatch repair genes <xref ref-type="bibr" rid="pone.0059064-Jass1">[7]</xref>. MSI in sporadic CRC is commonly due to methylation induced silencing of the <italic>MLH1</italic> gene <xref ref-type="bibr" rid="pone.0059064-Kane1">[8]</xref>.</p>
      <p>DNA methylation refers to the presence of a methyl group on a cytosine residue <xref ref-type="bibr" rid="pone.0059064-Bird1">[9]</xref>. DNA methylation of tumor suppressor genes leading to transcriptional inactivation has been identified as an important mechanism in human carcinogenesis <xref ref-type="bibr" rid="pone.0059064-Kondo1">[10]</xref>, <xref ref-type="bibr" rid="pone.0059064-Issa1">[11]</xref>. <italic>MLH1</italic> gene, as a number of suppressor genes, is prone to be silenced by promoter methylation in CRC <xref ref-type="bibr" rid="pone.0059064-Kane1">[8]</xref>, <xref ref-type="bibr" rid="pone.0059064-Herman1">[12]</xref>, <xref ref-type="bibr" rid="pone.0059064-Cunningham1">[13]</xref>.</p>
      <p>Since the first report of <italic>MLH1</italic> promoter methylation in sporadic colon tumors <xref ref-type="bibr" rid="pone.0059064-Kane1">[8]</xref>, the prevalence of <italic>MLH1</italic> promoter methylation have been widely studied not only in sporadic but also in LS CRC. However, the results are inconsistent. The frequency of <italic>MLH1</italic> promoter methylation in sporadic CRC varied from 0.0% <xref ref-type="bibr" rid="pone.0059064-Belshaw1">[14]</xref> to 66.9% <xref ref-type="bibr" rid="pone.0059064-Kumar1">[15]</xref>. It varied from 0.0% <xref ref-type="bibr" rid="pone.0059064-Menigatti1">[16]</xref> to 21.4% <xref ref-type="bibr" rid="pone.0059064-Park1">[17]</xref> in LS CRC.</p>
      <p><italic>BRAF</italic> and <italic>KRAS</italic> are important members of RAS/RAF/MAPK signaling pathway, which regulates cell growth, proliferation, differentiation, and apoptosis in malignant and nonmalignant cells <xref ref-type="bibr" rid="pone.0059064-Peyssonnaux1">[18]</xref>. <italic>BRAF</italic> mutation has been shown to be associated with <italic>MLH1</italic> promoter methylation <xref ref-type="bibr" rid="pone.0059064-Bettstetter1">[19]</xref>, <xref ref-type="bibr" rid="pone.0059064-Nagasaka1">[20]</xref>. Whereas, <italic>MLH1</italic> promoter methylation was few detected in <italic>KRAS</italic> mutant CRC <xref ref-type="bibr" rid="pone.0059064-deVogel1">[21]</xref>. The associations between <italic>MLH1</italic> promoter methylation and <italic>BRAF</italic> and <italic>KRAS</italic> mutation in CRC have been widely studied with inconsistent results <xref ref-type="bibr" rid="pone.0059064-Kumar1">[15]</xref>, <xref ref-type="bibr" rid="pone.0059064-deVogel1">[21]</xref>, <xref ref-type="bibr" rid="pone.0059064-Iacopetta1">[22]</xref>, <xref ref-type="bibr" rid="pone.0059064-Deng1">[23]</xref>. The associations between <italic>MLH1</italic> promoter methylation and other clinicopathological and molecular characteristics of CRC such as tumor location, tumor staging, tumor differentiation, family history, MSI, and <italic>MLH1</italic> protein expression were also widely studied. However, the results are inconsistent. Therefore, we conducted a systematic review and meta-analysis to accurately estimate the frequency of <italic>MLH1</italic> promoter methylation in LS and sporadic CRC, and the associations between <italic>MLH1</italic> promoter methylation and clinicopathological/molecular characteristics of CRC.</p>
    </sec>
    <sec id="s2" sec-type="methods">
      <title>Methods</title>
      <sec id="s2a">
        <title>Search Strategy and Selection Criteria</title>
        <p>We conducted a systematic literature search using PubMed and Embase from January 1, 1997 to September 7, 2012 to identify all the relevant English-language articles. The following keywords were used: “methylation” and “<italic>MLH1</italic>” and “promoter” and “colorectal cancer” and/or “carcinoma” or “tumor” or “neoplasm”. We also hand-searched the reference lists of the retrieved articles and reviews for additional articles.</p>
        <p>The inclusion/exclusion criteria were as follows: (1) papers on <italic>MLH1</italic> promoter methylation in unselected CRC were included. In contrast, papers that selected subgroups were excluded (such as selected based on age, tumor staging and ulcerative colitis-associated CRC); (2) sporadic CRC and/or LS related CRC remained as specific selected groups, often stratified by MSI status and/or <italic>MLH1</italic> expression loss; (3) data regarding the DNA methylation of tumor tissue of CRC were included in the pooled analysis, whereas data regarding the DNA methylation of normal colonic mucosa <xref ref-type="bibr" rid="pone.0059064-Ahlquist1">[24]</xref>, <xref ref-type="bibr" rid="pone.0059064-Nakagawa1">[25]</xref>, <xref ref-type="bibr" rid="pone.0059064-Menigatti2">[26]</xref>, serum <xref ref-type="bibr" rid="pone.0059064-Wallner1">[27]</xref>, <xref ref-type="bibr" rid="pone.0059064-Leung1">[28]</xref>, and peripheral blood leukocyte <xref ref-type="bibr" rid="pone.0059064-Zhou1">[29]</xref>, <xref ref-type="bibr" rid="pone.0059064-Miyakura1">[30]</xref>, <xref ref-type="bibr" rid="pone.0059064-Gazzoli1">[31]</xref> of CRC were excluded; (4) studies that investigated multiple CRCs were excluded <xref ref-type="bibr" rid="pone.0059064-Lawes1">[32]</xref>, <xref ref-type="bibr" rid="pone.0059064-Dykes1">[33]</xref>, <xref ref-type="bibr" rid="pone.0059064-Velayos1">[34]</xref>; (5) case reports were excluded; (6) repetitive reports were unified by using the latest or the largest edition; (7) paper with insufficient or duplicated data were excluded.</p>
      </sec>
      <sec id="s2b">
        <title>Data Extraction</title>
        <p>Two authors (X. and X.P) independently conducted literature searches to identify all possible papers that met the inclusion criteria. Disagreements were settled by consensus or a third review (Y.B.N) for adjudication. The following information were extracted from every eligible study: authors, publication year, continent, country, patient source, sample size, methylation detecting method, positive frequency, gender, family history, tumor location (proximal and distal), tumor staging, and promoter regions.</p>
      </sec>
      <sec id="s2c">
        <title>Classification of Family History</title>
        <p>Patients had no family history of cancer regardless of the onset age were categorized as sporadic CRC. LS was diagnosed if a patient with family history met either Amsterdam criteria (I or II) <xref ref-type="bibr" rid="pone.0059064-Vasen1">[35]</xref>, <xref ref-type="bibr" rid="pone.0059064-Vasen2">[36]</xref> or Bethesda criteria (original or revised) <xref ref-type="bibr" rid="pone.0059064-RodriguezBigas1">[37]</xref>, <xref ref-type="bibr" rid="pone.0059064-Umar1">[38]</xref> or confirmed with germline mutation in a DNA mismatch repair gene <xref ref-type="bibr" rid="pone.0059064-Hampel1">[39]</xref>, <xref ref-type="bibr" rid="pone.0059064-Ward1">[40]</xref>. The unselected CRC tumors were defined as patients from nature population or hospital-based. The unselected CRC tumors included sporadic and LS CRC, which were defined as total CRC.</p>
      </sec>
      <sec id="s2d">
        <title>Tumor Staging and Differentiation</title>
        <p>Tumor staging was categorized as I, II, III and IV stages based on the TNM classification (The Union for International Cancer Control [UICC]) <xref ref-type="bibr" rid="pone.0059064-Sobin1">[41]</xref>. Stage I: Cancer has begun to spread, but is still in the inner lining. Stage II: Cancer has spread to other organs near the colon or rectum. It has not reached lymph nodes. Stage III: Cancer has spread to lymph nodes, but has not been carried to distant parts of the body. Stage IV: Cancer has been carried through the lymph system to distant parts of the body. Differentiation was graded on a scale of poor, moderate or well differentiation.</p>
      </sec>
      <sec id="s2e">
        <title>Promoter Regions</title>
        <p>Promoter regions tested were noted as the A, B, C and D regions proposed by Deng et al. <xref ref-type="bibr" rid="pone.0059064-Deng2">[42]</xref>, where primer sequences were given. Promoter regions were checked against the sequence −1000 to −1, relative to the start codon of <italic>MLH1</italic>.</p>
      </sec>
      <sec id="s2f">
        <title>Molecular Classification</title>
        <p>MSI is typically assessed by analyzing five microsatellite markers (BAT25, BAT26, D2S123, D5S346, and D17S250) suggested by the National Cancer Institute <xref ref-type="bibr" rid="pone.0059064-Boland1">[43]</xref>. One study expanded this panel to ten markers, which made the diagnosis of MSI CRC easier <xref ref-type="bibr" rid="pone.0059064-Umar1">[38]</xref>. In this meta-analysis, three categories of MSI status were defined according to the following criteria: two or more loci out of five loci with instability (or ≥30–40% of loci if a larger panel of markers was used) was defined as MSI-H; one locus with instability (or &lt;30–40% of loci in larger panels) was defined as lower-level microsatellite instability (MSI-L); and no loci with instability (or no apparent instability in larger panels) was defined as microsatellite stable (MSS). For papers without detailed information about MSI-H and MSI-L, only two levels of microsatellite instability status could be categorized: MSI-positive (MSI) and MSI-negative (MSS). <italic>BRAF</italic> and <italic>KRAS</italic> status were classified into mutant and wild type. <italic>MLH1</italic> protein expression status was defined as positive or negative.</p>
      </sec>
      <sec id="s2g">
        <title>Statistical Analysis</title>
        <p>The pooled frequency of <italic>MLH1</italic> promoter methylation and 95% confidence intervals (95% CI) were estimated. The frequency of <italic>MLH1</italic> promoter methylation was compared in different tumor characteristics. Heterogeneity among studies was evaluated with Cochran’s Q test <xref ref-type="bibr" rid="pone.0059064-DerSimonian1">[44]</xref> and the <italic>I<sup>2</sup></italic> statistic <xref ref-type="bibr" rid="pone.0059064-Higgins1">[45]</xref>, <xref ref-type="bibr" rid="pone.0059064-DerSimonian2">[46]</xref>. When heterogeneity was not an issue (<italic>I<sup>2</sup></italic> values &lt;50%), a fixed effect model was used to calculate parameters. If there was substantial heterogeneity (<italic>I<sup>2</sup></italic> values ≥50%), a random-effects model was used to pool data and attempt to identify potential sources of heterogeneity based on subgroup analyses. The pooled OR was estimated for the association between <italic>MLH1</italic> promoter methylation and clinicopathological, molecular features. <italic>P</italic> values tailed less than 0.05 were considered statistically significant.</p>
        <p>Publication bias was evaluated with funnel plot, Begg’s rank correlation <xref ref-type="bibr" rid="pone.0059064-Begg1">[47]</xref>, and Egger’s regression <xref ref-type="bibr" rid="pone.0059064-Egger1">[48]</xref>. If publication bias existed, the trim and fill method was used to adjust the pooled frequency, pooled OR and 95% CI <xref ref-type="bibr" rid="pone.0059064-Duval1">[49]</xref>. Data were calculated with Comprehensive Meta-Analysis V2.</p>
      </sec>
    </sec>
    <sec id="s3">
      <title>Results</title>
      <p>752 relevant articles were identified for initial review according to the inclusion and exclusion criteria. After screening, information for 10528 individuals from 96 studies was reviewed and included in the meta-analyses. <xref ref-type="fig" rid="pone-0059064-g001">Figure 1</xref> showed the detailed selection process of articles.</p>
      <fig id="pone-0059064-g001" position="float">
        <object-id pub-id-type="doi">10.1371/journal.pone.0059064.g001</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Flow diagram of study selection.</title>
        </caption>
        <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059064.g001" position="float" xlink:type="simple"/>
      </fig>
      <sec id="s3a">
        <title>Frequency of <italic>MLH1</italic> Promoter Methylation in Total CRC Tumors</title>
        <p>Overall, there were 19 studies with 5584 patients demonstrating <italic>MLH1</italic> promoter methylation in total CRC tumors. The total frequency of <italic>MLH1</italic> promoter methylation was 20.3% (95% CI: 16.8–24.1%) (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>, <xref ref-type="fig" rid="pone-0059064-g002">Figure 2</xref>). There was significant heterogeneity among the studies (<italic>I<sup>2</sup></italic> = 87.896%).</p>
        <fig id="pone-0059064-g002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0059064.g002</object-id>
          <label>Figure 2</label>
          <caption>
            <title>The pooled frequency of <italic>MLH1</italic> promoter methylation in CRC.</title>
          </caption>
          <graphic mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059064.g002" position="float" xlink:type="simple"/>
        </fig>
        <table-wrap id="pone-0059064-t001" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0059064.t001</object-id>
          <label>Table 1</label>
          <caption>
            <title>Pooled frequency of <italic>MLH1</italic> promoter methylation in colorectal cancer patients with different clinicopathological features.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0059064-t001-1" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059064.t001" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Classification</td>
                  <td align="left" rowspan="1" colspan="1">No. ofstudies</td>
                  <td align="left" rowspan="1" colspan="1">No. ofdetectedcases</td>
                  <td align="left" rowspan="1" colspan="1">No. ofmethylationcases</td>
                  <td align="left" rowspan="1" colspan="1">Pooled frequencyand 95%CI (%)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>P</italic>
                  </td>
                  <td colspan="2" align="left" rowspan="1">Heterogeneity</td>
                  <td colspan="2" align="left" rowspan="1">Publication bias</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>I<sup>2</sup></italic> (%)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>P</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Begg’stest <italic>P</italic></td>
                  <td align="left" rowspan="1" colspan="1">Egger’stest <italic>P</italic></td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CRC(total)</td>
                  <td align="left" rowspan="1" colspan="1">19</td>
                  <td align="left" rowspan="1" colspan="1">5584</td>
                  <td align="left" rowspan="1" colspan="1">1005</td>
                  <td align="left" rowspan="1" colspan="1">20.3(16.8–24.1)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">87.896</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.132</td>
                  <td align="left" rowspan="1" colspan="1">0.472</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Subject source<xref ref-type="table-fn" rid="nt103">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Hospital-based</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">2335</td>
                  <td align="left" rowspan="1" colspan="1">449</td>
                  <td align="left" rowspan="1" colspan="1">20.5(15.6–26.5)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">86.938</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.589</td>
                  <td align="left" rowspan="1" colspan="1">0.761</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Population-based</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">3249</td>
                  <td align="left" rowspan="1" colspan="1">556</td>
                  <td align="left" rowspan="1" colspan="1">16.4(12.1–22.0)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">93.166</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.497</td>
                  <td align="left" rowspan="1" colspan="1">0.244</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Family history</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LS</td>
                  <td align="left" rowspan="1" colspan="1">8</td>
                  <td align="left" rowspan="1" colspan="1">243</td>
                  <td align="left" rowspan="1" colspan="1">31</td>
                  <td align="left" rowspan="1" colspan="1">16.4(11.9–22.0)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">15.564</td>
                  <td align="left" rowspan="1" colspan="1">0.165</td>
                  <td align="left" rowspan="1" colspan="1">0.048</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SCRC</td>
                  <td align="left" rowspan="1" colspan="1">29</td>
                  <td align="left" rowspan="1" colspan="1">3583</td>
                  <td align="left" rowspan="1" colspan="1">739</td>
                  <td align="left" rowspan="1" colspan="1">18.7(14.7–23.6)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">90.505</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.143</td>
                  <td align="left" rowspan="1" colspan="1">0.032</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Gender<xref ref-type="table-fn" rid="nt103">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Female</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">555</td>
                  <td align="left" rowspan="1" colspan="1">124</td>
                  <td align="left" rowspan="1" colspan="1">20.8(15.6–27.2)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">48.843</td>
                  <td align="left" rowspan="1" colspan="1">0.082</td>
                  <td align="left" rowspan="1" colspan="1">0.851</td>
                  <td align="left" rowspan="1" colspan="1">0.255</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Male</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">699</td>
                  <td align="left" rowspan="1" colspan="1">102</td>
                  <td align="left" rowspan="1" colspan="1">11.8(6.9–16.5)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">75.322</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">0.348</td>
                  <td align="left" rowspan="1" colspan="1">0.136</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Location<xref ref-type="table-fn" rid="nt103">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Proximal</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">474</td>
                  <td align="left" rowspan="1" colspan="1">139</td>
                  <td align="left" rowspan="1" colspan="1">29.6(20.4–40.8)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">76.757</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">0.573</td>
                  <td align="left" rowspan="1" colspan="1">0.795</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Distal</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">698</td>
                  <td align="left" rowspan="1" colspan="1">71</td>
                  <td align="left" rowspan="1" colspan="1">6.5(3.0–13.4)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">74.442</td>
                  <td align="left" rowspan="1" colspan="1">0.002</td>
                  <td align="left" rowspan="1" colspan="1">0.348</td>
                  <td align="left" rowspan="1" colspan="1">0.029</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">UICC stage<xref ref-type="table-fn" rid="nt103">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">I &amp; II</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">160</td>
                  <td align="left" rowspan="1" colspan="1">34</td>
                  <td align="left" rowspan="1" colspan="1">22.4(15.6–31.0)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">20.902</td>
                  <td align="left" rowspan="1" colspan="1">0.285</td>
                  <td align="left" rowspan="1" colspan="1">0.174</td>
                  <td align="left" rowspan="1" colspan="1">0.028</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">III &amp; IV</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">123</td>
                  <td align="left" rowspan="1" colspan="1">24</td>
                  <td align="left" rowspan="1" colspan="1">25.5(9.3–53.5)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.083</td>
                  <td align="left" rowspan="1" colspan="1">82.686</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">1.000</td>
                  <td align="left" rowspan="1" colspan="1">0.807</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Differentiation<xref ref-type="table-fn" rid="nt103">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Poor</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">182</td>
                  <td align="left" rowspan="1" colspan="1">56</td>
                  <td align="left" rowspan="1" colspan="1">31.0(24.6–38.1)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.637</td>
                  <td align="left" rowspan="1" colspan="1">0.188</td>
                  <td align="left" rowspan="1" colspan="1">0.540</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Moderate or Well</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">769</td>
                  <td align="left" rowspan="1" colspan="1">130</td>
                  <td align="left" rowspan="1" colspan="1">17.6(11.9–25.3)<xref ref-type="table-fn" rid="nt102">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">68.101</td>
                  <td align="left" rowspan="1" colspan="1">0.008</td>
                  <td align="left" rowspan="1" colspan="1">0.188</td>
                  <td align="left" rowspan="1" colspan="1">0.796</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt101">
              <label/>
              <p>Abbreviations: CRC, colorectal cancer; LS, lynch syndrome; SCRC, sporadic colorectal cancer.</p>
            </fn>
            <fn id="nt102">
              <label>*</label>
              <p>Random effect estimate.</p>
            </fn>
            <fn id="nt103">
              <label>**</label>
              <p>It is only pooled data with total colorectal cancer.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3b">
        <title>Family History</title>
        <p>The frequency of <italic>MLH1</italic> promoter methylation was 18.7% (95% CI: 14.7–23.6%) in 3583 sporadic CRC of 29 studies and 16.4% (95% CI: 11.9–22.0%) in 243 LS reported in eight studies (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>). The frequency of <italic>MLH1</italic> promoter methylation in sporadic MSI-H and LS CRC MSI-H were 73.6% (95% CI: 67.3–79.0%) and 15.3% (95% CI: 8.8–25.4%), respectively (<xref ref-type="table" rid="pone-0059064-t002">Table 2</xref>). For MSI-H CRC, significant association between <italic>MLH1</italic> promoter methylation and family history was observed (pooled OR = 20.828, 95% CI: 4.056–106.950; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 55.363%; <xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>), when pooled data on four studies <xref ref-type="bibr" rid="pone.0059064-Yamamoto1">[50]</xref>, <xref ref-type="bibr" rid="pone.0059064-Julie1">[51]</xref>, <xref ref-type="bibr" rid="pone.0059064-Potocnik1">[52]</xref>, <xref ref-type="bibr" rid="pone.0059064-Poynter1">[53]</xref>.</p>
        <table-wrap id="pone-0059064-t002" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0059064.t002</object-id>
          <label>Table 2</label>
          <caption>
            <title>Pooled frequency of <italic>MLH1</italic> promoter methylation in colorectal cancer patients with different molecular features.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0059064-t002-2" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059064.t002" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Classification</td>
                  <td align="left" rowspan="1" colspan="1">No. ofstudies</td>
                  <td align="left" rowspan="1" colspan="1">No. ofdetectedcases</td>
                  <td align="left" rowspan="1" colspan="1">No. ofmethylationcases</td>
                  <td align="left" rowspan="1" colspan="1">Frequency and95%CI (%)</td>
                  <td colspan="2" align="left" rowspan="1">Heterogeneity</td>
                  <td colspan="2" align="left" rowspan="1">Publication bias</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>I<sup>2</sup></italic> (%)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>P</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Begg’stest <italic>P</italic></td>
                  <td align="left" rowspan="1" colspan="1">Egger’stest <italic>P</italic></td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CRC(total) MSI Status</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI-H</td>
                  <td align="left" rowspan="1" colspan="1">12</td>
                  <td align="left" rowspan="1" colspan="1">968</td>
                  <td align="left" rowspan="1" colspan="1">566</td>
                  <td align="left" rowspan="1" colspan="1">62.6(54.0–70.4)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">78.288</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.411</td>
                  <td align="left" rowspan="1" colspan="1">0.049</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI-L</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">344</td>
                  <td align="left" rowspan="1" colspan="1">24</td>
                  <td align="left" rowspan="1" colspan="1">12.2(3.0–38.2)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">90.733</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">1.000</td>
                  <td align="left" rowspan="1" colspan="1">0.845</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI</td>
                  <td align="left" rowspan="1" colspan="1">16</td>
                  <td align="left" rowspan="1" colspan="1">1325</td>
                  <td align="left" rowspan="1" colspan="1">576</td>
                  <td align="left" rowspan="1" colspan="1">55.8(45.2–65.8)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">89.197</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.280</td>
                  <td align="left" rowspan="1" colspan="1">0.002</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSS</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">1791</td>
                  <td align="left" rowspan="1" colspan="1">155</td>
                  <td align="left" rowspan="1" colspan="1">5.2(2.2–11.6)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">88.938</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.655</td>
                  <td align="left" rowspan="1" colspan="1">0.068</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LS- MSI-H</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">95</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">15.3(8.8–25.4)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.517</td>
                  <td align="left" rowspan="1" colspan="1">0.050</td>
                  <td align="left" rowspan="1" colspan="1">0.160</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SCRC MSI Status</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI-H</td>
                  <td align="left" rowspan="1" colspan="1">11</td>
                  <td align="left" rowspan="1" colspan="1">249</td>
                  <td align="left" rowspan="1" colspan="1">188</td>
                  <td align="left" rowspan="1" colspan="1">73.6(67.3–79.0)</td>
                  <td align="left" rowspan="1" colspan="1">42.882</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.119</td>
                  <td align="left" rowspan="1" colspan="1">0.228</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">193</td>
                  <td align="left" rowspan="1" colspan="1">125</td>
                  <td align="left" rowspan="1" colspan="1">67.3(47.1–82.7)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">79.255</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.293</td>
                  <td align="left" rowspan="1" colspan="1">0.253</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSS</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">264</td>
                  <td align="left" rowspan="1" colspan="1">51</td>
                  <td align="left" rowspan="1" colspan="1">17.5(10.0–29.0)</td>
                  <td align="left" rowspan="1" colspan="1">35.109</td>
                  <td align="left" rowspan="1" colspan="1">0.202</td>
                  <td align="left" rowspan="1" colspan="1">0.174</td>
                  <td align="left" rowspan="1" colspan="1">0.014</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CRC(total) MLH1expression</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Positive</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">67</td>
                  <td align="left" rowspan="1" colspan="1">7</td>
                  <td align="left" rowspan="1" colspan="1">11.9(1.5–53.8)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">83.531</td>
                  <td align="left" rowspan="1" colspan="1">0.014</td>
                  <td align="left" rowspan="1" colspan="1">–</td>
                  <td align="left" rowspan="1" colspan="1">–</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Negative</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">106</td>
                  <td align="left" rowspan="1" colspan="1">73</td>
                  <td align="left" rowspan="1" colspan="1">66.5(44.4–83.2)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">73.534</td>
                  <td align="left" rowspan="1" colspan="1">0.004</td>
                  <td align="left" rowspan="1" colspan="1">1.000</td>
                  <td align="left" rowspan="1" colspan="1">0.981</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI-H- Loss of <italic>MLH1</italic> protein</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">247</td>
                  <td align="left" rowspan="1" colspan="1">201</td>
                  <td align="left" rowspan="1" colspan="1">80.8(75.3–85.3)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.644</td>
                  <td align="left" rowspan="1" colspan="1">0.624</td>
                  <td align="left" rowspan="1" colspan="1">0.321</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SCRC<italic>-MLH1</italic> expression</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Positive</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">308</td>
                  <td align="left" rowspan="1" colspan="1">25</td>
                  <td align="left" rowspan="1" colspan="1">9.8(3.4–25.2)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">76.529</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">0.851</td>
                  <td align="left" rowspan="1" colspan="1">0.366</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Negative</td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">156</td>
                  <td align="left" rowspan="1" colspan="1">108</td>
                  <td align="left" rowspan="1" colspan="1">69.8(45.5–86.5)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">78.786</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.089</td>
                  <td align="left" rowspan="1" colspan="1">0.083</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI-H- Loss of <italic>MLH1</italic> protein</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">64</td>
                  <td align="left" rowspan="1" colspan="1">56</td>
                  <td align="left" rowspan="1" colspan="1">86.3(75.3–92.9)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.618</td>
                  <td align="left" rowspan="1" colspan="1">0.602</td>
                  <td align="left" rowspan="1" colspan="1">0.782</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">LS- Loss of <italic>MLH1</italic> protein</td>
                  <td align="left" rowspan="1" colspan="1">5</td>
                  <td align="left" rowspan="1" colspan="1">169</td>
                  <td align="left" rowspan="1" colspan="1">65</td>
                  <td align="left" rowspan="1" colspan="1">37.8 (25.3–52.1)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">62.057</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.142</td>
                  <td align="left" rowspan="1" colspan="1">0.155</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CRC(total)<italic>BRAF</italic> situation</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mutant</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">138</td>
                  <td align="left" rowspan="1" colspan="1">70</td>
                  <td align="left" rowspan="1" colspan="1">53.2(27.7–77.2)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">67.744</td>
                  <td align="left" rowspan="1" colspan="1">0.045</td>
                  <td align="left" rowspan="1" colspan="1">0.602</td>
                  <td align="left" rowspan="1" colspan="1">0.572</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Wild type</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">764</td>
                  <td align="left" rowspan="1" colspan="1">113</td>
                  <td align="left" rowspan="1" colspan="1">13.7(5.1–32.0)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">90.433</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.602</td>
                  <td align="left" rowspan="1" colspan="1">0.792</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CRC(total)<italic>KRAS</italic> situation</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mutant</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">353</td>
                  <td align="left" rowspan="1" colspan="1">41</td>
                  <td align="left" rowspan="1" colspan="1">14.0(10.2–19.0)</td>
                  <td align="left" rowspan="1" colspan="1">9.722</td>
                  <td align="left" rowspan="1" colspan="1">0.330</td>
                  <td align="left" rowspan="1" colspan="1">0.117</td>
                  <td align="left" rowspan="1" colspan="1">0.119</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Wild type</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">570</td>
                  <td align="left" rowspan="1" colspan="1">135</td>
                  <td align="left" rowspan="1" colspan="1">21.8(13.2–33.8)<xref ref-type="table-fn" rid="nt105">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">77.209</td>
                  <td align="left" rowspan="1" colspan="1">0.012</td>
                  <td align="left" rowspan="1" colspan="1">0.602</td>
                  <td align="left" rowspan="1" colspan="1">0.699</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt104">
              <label/>
              <p>Abbreviations: CRC, colorectal cancer; LS, lynch syndrome; MMR, mismatch repair; SCRC, sporadic colorectal cancer; MSI, Microsatellite instability; MSS, microsatellite stability; MSI-L, lower-level microsatellite instability; MSI-H, high-level microsatellite instability.</p>
            </fn>
            <fn id="nt105">
              <label>*</label>
              <p>Random effect estimate.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <table-wrap id="pone-0059064-t003" position="float">
          <object-id pub-id-type="doi">10.1371/journal.pone.0059064.t003</object-id>
          <label>Table 3</label>
          <caption>
            <title>Pooled associations between <italic>MLH1</italic> promoter methylation and clinicopathological and molecular features.</title>
          </caption>
          <alternatives>
            <graphic id="pone-0059064-t003-3" position="float" mimetype="image" xlink:href="info:doi/10.1371/journal.pone.0059064.t003" xlink:type="simple"/>
            <table>
              <colgroup span="1">
                <col align="left" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
                <col align="center" span="1"/>
              </colgroup>
              <thead>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Classification</td>
                  <td align="left" rowspan="1" colspan="1">No. of studies</td>
                  <td align="left" rowspan="1" colspan="1">OR and 95%CI</td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>P</italic>
                  </td>
                  <td colspan="2" align="left" rowspan="1">Heterogeneity</td>
                  <td colspan="2" align="left" rowspan="1">Publication bias</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"><italic>I<sup>2</sup></italic> (%)</td>
                  <td align="left" rowspan="1" colspan="1">
                    <italic>P</italic>
                  </td>
                  <td align="left" rowspan="1" colspan="1">Begg’s test <italic>P</italic></td>
                  <td align="left" rowspan="1" colspan="1">Egger’s test <italic>P</italic></td>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td align="left" rowspan="1" colspan="1">SCRC- MSI-H vs. LS- MSI-H</td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">20.828(4.056–106.950)<xref ref-type="table-fn" rid="nt108">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">55.363</td>
                  <td align="left" rowspan="1" colspan="1">0.081</td>
                  <td align="left" rowspan="1" colspan="1">0.497</td>
                  <td align="left" rowspan="1" colspan="1">0.225</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Female vs. Male<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">1.641(1.215–2.215)</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">33.819</td>
                  <td align="left" rowspan="1" colspan="1">0.183</td>
                  <td align="left" rowspan="1" colspan="1">0.851</td>
                  <td align="left" rowspan="1" colspan="1">0.438</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Proximal vs. Distal<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">3.804(2.715–5.329)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">46.541</td>
                  <td align="left" rowspan="1" colspan="1">0.096</td>
                  <td align="left" rowspan="1" colspan="1">0.348</td>
                  <td align="left" rowspan="1" colspan="1">0.042</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">UICC stage (I &amp; II vs. III &amp; IV)<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">1.044(0.441–2.471)</td>
                  <td align="left" rowspan="1" colspan="1">0.922</td>
                  <td align="left" rowspan="1" colspan="1">42.854</td>
                  <td align="left" rowspan="1" colspan="1">0.154</td>
                  <td align="left" rowspan="1" colspan="1">0.497</td>
                  <td align="left" rowspan="1" colspan="1">0.773</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Poor vs. Moderate or Well<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">2.131(1.464–3.102)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.674</td>
                  <td align="left" rowspan="1" colspan="1">0.573</td>
                  <td align="left" rowspan="1" colspan="1">0.430</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI vs. MSS<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">10</td>
                  <td align="left" rowspan="1" colspan="1">27.096(13.717–53.526)<xref ref-type="table-fn" rid="nt108">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">59.001</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.531</td>
                  <td align="left" rowspan="1" colspan="1">0.438</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI-H vs. Non- MSI-H<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">17.061(3.850–75.610)<xref ref-type="table-fn" rid="nt108">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">69.023</td>
                  <td align="left" rowspan="1" colspan="1">0.021</td>
                  <td align="left" rowspan="1" colspan="1">0.497</td>
                  <td align="left" rowspan="1" colspan="1">0.336</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI vs. MSS<xref ref-type="table-fn" rid="nt110">***</xref></td>
                  <td align="left" rowspan="1" colspan="1">4</td>
                  <td align="left" rowspan="1" colspan="1">33.549(3.942–285.515)<xref ref-type="table-fn" rid="nt108">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">81.145</td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">0.497</td>
                  <td align="left" rowspan="1" colspan="1">0.297</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"><italic>MLH1</italic> expression<xref ref-type="table-fn" rid="nt110">***</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Negative vs. Positive</td>
                  <td align="left" rowspan="1" colspan="1">6</td>
                  <td align="left" rowspan="1" colspan="1">14.919(6.427–34.631)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">35.469</td>
                  <td align="left" rowspan="1" colspan="1">0.171</td>
                  <td align="left" rowspan="1" colspan="1">0.573</td>
                  <td align="left" rowspan="1" colspan="1">0.455</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"><italic>BRAF</italic> situation</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mutant vs. Wild type<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">9.419(2.613–33.953)<xref ref-type="table-fn" rid="nt108">*</xref></td>
                  <td align="left" rowspan="1" colspan="1">0.001</td>
                  <td align="left" rowspan="1" colspan="1">67.030</td>
                  <td align="left" rowspan="1" colspan="1">0.048</td>
                  <td align="left" rowspan="1" colspan="1">0.602</td>
                  <td align="left" rowspan="1" colspan="1">0.115</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">CRC- MSI-H<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"> Mutant vs. Wild type</td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">37.615(10.011–141.311)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.913</td>
                  <td align="left" rowspan="1" colspan="1">0.117</td>
                  <td align="left" rowspan="1" colspan="1">0.251</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"><italic>KRAS</italic> situation</td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">Mutant vs. Wild type<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1">3</td>
                  <td align="left" rowspan="1" colspan="1">0.476(0.322–0.703)</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">49.293</td>
                  <td align="left" rowspan="1" colspan="1">0.139</td>
                  <td align="left" rowspan="1" colspan="1">0.117</td>
                  <td align="left" rowspan="1" colspan="1">0.161</td>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1">MSI- CRC<xref ref-type="table-fn" rid="nt109">**</xref></td>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                  <td align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td align="left" rowspan="1" colspan="1"> Mutant vs. Wild type</td>
                  <td align="left" rowspan="1" colspan="1">2</td>
                  <td align="left" rowspan="1" colspan="1">0.340(0.167–0.693)</td>
                  <td align="left" rowspan="1" colspan="1">0.003</td>
                  <td align="left" rowspan="1" colspan="1">0.000</td>
                  <td align="left" rowspan="1" colspan="1">0.674</td>
                  <td align="left" rowspan="1" colspan="1">–</td>
                  <td align="left" rowspan="1" colspan="1">–</td>
                </tr>
              </tbody>
            </table>
          </alternatives>
          <table-wrap-foot>
            <fn id="nt106">
              <label/>
              <p>Abbreviations: CRC, colorectal cancer; LS, lynch syndrome; SCRC, sporadic colorectal cancer; MSI, Microsatellite instability; MSS, microsatellite stability;</p>
            </fn>
            <fn id="nt107">
              <label/>
              <p>MSI-H, high-level microsatellite instability.</p>
            </fn>
            <fn id="nt108">
              <label>*</label>
              <p>Random effect estimate.</p>
            </fn>
            <fn id="nt109">
              <label>**</label>
              <p>It is only pooled data with total colorectal cancer.</p>
            </fn>
            <fn id="nt110">
              <label>***</label>
              <p>It is only pooled data with sporadic colorectal cancer.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="s3c">
        <title>Gender</title>
        <p>Gender information was available for 6 of the 19 studies with a total of 555 female and 699 male patients <xref ref-type="bibr" rid="pone.0059064-Menigatti1">[16]</xref>, <xref ref-type="bibr" rid="pone.0059064-deVogel1">[21]</xref>, <xref ref-type="bibr" rid="pone.0059064-Iacopetta1">[22]</xref>, <xref ref-type="bibr" rid="pone.0059064-Lind1">[54]</xref>, <xref ref-type="bibr" rid="pone.0059064-Shi1">[55]</xref>, <xref ref-type="bibr" rid="pone.0059064-Gay1">[56]</xref>. The <italic>MLH1</italic> promoter methylation in female and male were 20.8% (95% CI: 15.6–27.2%) and 11.8% (95% CI: 6.9–16.5%) in total CRC group (pooled OR = 1.641, 95% CI = 1.215–2.215; <italic>P = </italic>0.001; <italic>I<sup>2</sup></italic> = 33.819%) (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref> and <xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>).</p>
      </sec>
      <sec id="s3d">
        <title>Tumor Location</title>
        <p><italic>MLH1</italic> promoter methylation was observed in 29.6% (95% CI: 20.4–40.8%) of the 474 proximal tumors and 6.5% (95% CI: 3.0–13.4%) of the 698 distal tumors in six studies (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>). Significant association was observed between <italic>MLH1</italic> promoter methylation and tumor location (pooled OR = 3.804, 95% CI: 2.715–5.329; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 46.541%) (<xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>). These data were based on six studies covering a total of 1172 patients (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>).</p>
      </sec>
      <sec id="s3e">
        <title>Tumor Staging</title>
        <p>The pooled prevalence of <italic>MLH1</italic> promoter methylation and pooled OR for the association between <italic>MLH1</italic>promoter methylation and the UICC stage were estimated in four studies <xref ref-type="bibr" rid="pone.0059064-Lind1">[54]</xref>, <xref ref-type="bibr" rid="pone.0059064-Gay1">[56]</xref>, <xref ref-type="bibr" rid="pone.0059064-Grady1">[57]</xref>, <xref ref-type="bibr" rid="pone.0059064-Brandes1">[58]</xref> (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref> and <xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>). The pooled prevalence of <italic>MLH1</italic> promoter methylation in stages I &amp; II and in stages III &amp; IV were 22.4% (95% CI: 15.6–31.0%) and 25.5% (95% CI: 9.3–53.5%), respectively (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>). The association between <italic>MLH1</italic> promoter methylation and tumor staging was not significant (pooled OR = 1.044, 95% CI: 0.441–2.471; <italic>P = </italic>0.922; <italic>I<sup>2</sup></italic> = 42.854%) (<xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>).</p>
      </sec>
      <sec id="s3f">
        <title>Tumor Differentiation</title>
        <p>Six studies <xref ref-type="bibr" rid="pone.0059064-Menigatti1">[16]</xref>, <xref ref-type="bibr" rid="pone.0059064-deVogel1">[21]</xref>, <xref ref-type="bibr" rid="pone.0059064-Lind1">[54]</xref>, <xref ref-type="bibr" rid="pone.0059064-Shi1">[55]</xref>, <xref ref-type="bibr" rid="pone.0059064-Gay1">[56]</xref>, <xref ref-type="bibr" rid="pone.0059064-Grady1">[57]</xref> addressed the frequency of <italic>MLH1</italic> promoter methylation in total CRC according to tumor differentiation. The frequency of <italic>MLH1</italic> promoter methylation was 31.0% (95% CI, 24.6–38.1%) in 182 poor-differentiated CRC and 17.6% (95% CI, 11.9–25.3%) in 769 moderate or well-differentiated CRC, respectively (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>). <italic>MLH1</italic> promoter methylation in poor-differentiated CRC was significantly higher than in moderate or well-differentiated CRC (pooled OR = 2.131, 95% CI, 1.464–3.102; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 0.000%) (<xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>).</p>
      </sec>
      <sec id="s3g">
        <title>Microsatellite Instability</title>
        <p>For total CRC, <italic>MLH1</italic> promoter methylation was detected in 62.6% (95% CI: 54.0–70.4%) of the 968 MSI-H CRC in 12 studies, 12.2% (95% CI: 3.0–38.2%) of the 344 MSI-L CRC in four studies, 55.8% (95% CI: 45.2–65.8%) of the 1325 MSI CRC in 16 studies, and 5.2% (95% CI: 2.2–11.6%) of the 1791 MSS CRC in 10 studies (<italic>P</italic>&lt;0.001), respectively (<xref ref-type="table" rid="pone-0059064-t002">Table 2</xref>). Significant differences were found between MSI vs. MSS, MSI-H vs. MSS, and MSI-H vs. MSI-L (<italic>P</italic>&lt;0.001, <italic>P</italic>&lt;0.001, and <italic>P</italic>&lt;0.001, respectively). Whereas, no difference was observed between MSI-L and MSS (<italic>P</italic> = 0.380). For sporadic CRC, the pooled prevalence of <italic>MLH1</italic> promoter methylation was 73.6% (95% CI: 67.3–79.0%) in MSI-H CRC, 67.3% (95% CI: 47.1–82.7%) in MSI CRC, and 17.5% (95% CI: 10.0–29.0%) in MSS CRC (<italic>P</italic>&lt;0.001; <xref ref-type="table" rid="pone-0059064-t002">Table 2</xref>). In addition, for the 10 studies <xref ref-type="bibr" rid="pone.0059064-Menigatti1">[16]</xref>, <xref ref-type="bibr" rid="pone.0059064-Iacopetta1">[22]</xref>, <xref ref-type="bibr" rid="pone.0059064-Poynter1">[53]</xref>, <xref ref-type="bibr" rid="pone.0059064-Lind1">[54]</xref>, <xref ref-type="bibr" rid="pone.0059064-Grady1">[57]</xref>, <xref ref-type="bibr" rid="pone.0059064-Anacleto1">[59]</xref>, <xref ref-type="bibr" rid="pone.0059064-Samowitz1">[60]</xref>, <xref ref-type="bibr" rid="pone.0059064-Shannon1">[61]</xref>, <xref ref-type="bibr" rid="pone.0059064-Kuismanen1">[62]</xref>, <xref ref-type="bibr" rid="pone.0059064-Yiu1">[63]</xref> that provided both MSI and MSS status in total CRC, the pooled OR for the association between <italic>MLH1</italic> promoter methylation and MSI status (MSI vs. MSS) was 27.096 (95% CI: 13.717–53.526; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 59.001%; <xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>, <xref ref-type="supplementary-material" rid="pone.0059064.s001">Figure S1</xref>).</p>
      </sec>
      <sec id="s3h">
        <title><italic>MLH1</italic> Protein Expression</title>
        <p>In tumors with a loss of <italic>MLH1</italic> protein expression, <italic>MLH1</italic> promoter methylation was detected in 66.5% (95% CI: 44.4–83.2%) of the 106 total CRC, 80.8% (95% CI: 75.3–85.3%) of the 247 MSI-H CRC, 69.8% (95% CI: 45.5–86.5%) of the 156 sporadic CRC, and 37.8% (95% CI: 25.3–52.1%) of the 169 LS tumors (<italic>P</italic>&lt;0.001). Significant differences were observed when comparing LS tumors vs. total CRC, LS tumors vs. sporadic CRC, and LS tumors vs. MSI-H CRC tumors (<italic>P</italic> = 0.032, <italic>P</italic>&lt;0.001, and <italic>P</italic> = 0.026, respectively). For tumors with <italic>MLH1</italic> protein expression, <italic>MLH1</italic> promoter methylation was detected in 11.9% (95% CI: 1.5–53.8%) of the 67 total CRC and in 9.8% (95% CI: 3.4–25.2%) of the 308 sporadic CRC (<italic>P</italic> = 0.862; <xref ref-type="table" rid="pone-0059064-t002">Table 2</xref>). Six studies <xref ref-type="bibr" rid="pone.0059064-Huang1">[64]</xref>, <xref ref-type="bibr" rid="pone.0059064-Fox1">[65]</xref>, <xref ref-type="bibr" rid="pone.0059064-Vilkin1">[66]</xref>, <xref ref-type="bibr" rid="pone.0059064-Lee1">[67]</xref>, <xref ref-type="bibr" rid="pone.0059064-Arnold1">[68]</xref>, <xref ref-type="bibr" rid="pone.0059064-Strazzullo1">[69]</xref> provided expression status as a loss of <italic>MLH1</italic> protein expression in 308 cases and <italic>MLH1</italic> protein expression in 75 cases of sporadic CRC. The pooled analysis showed significantly association between <italic>MLH1</italic> promoter methylation and <italic>MLH1</italic> protein expression (OR = 14.919, 95% CI: 6.427–34.631%; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 35.469%) (<xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>).</p>
      </sec>
      <sec id="s3i">
        <title><italic>BRAF</italic> Mutation</title>
        <p>The pooled prevalence of <italic>MLH1</italic> promoter methylation in 138 <italic>BRAF</italic>-mutated and 764 <italic>BRAF</italic> wild type CRC was 53.2% (95% CI: 27.7–77.2%) and 13.7% (95% CI: 5.1–32.0%) in three studies (pooled OR = 9.419; 95% CI: 2.613–33.953; <italic>P = </italic>0.001; <italic>I<sup>2</sup></italic> = 67.030%) (<xref ref-type="table" rid="pone-0059064-t002">Table 2</xref> and <xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>). For the three studies that provided both MSI-H and <italic>BRAF</italic> mutation status in CRC, the pooled OR for the association between <italic>BRAF</italic> mutation status and <italic>MLH1</italic> promoter methylation was 37.615 in MSI-H CRC (95% CI: 10.011–141.311; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 0.000%) (<xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>).</p>
      </sec>
      <sec id="s3j">
        <title><italic>KRAS</italic> Mutation</title>
        <p>The pooled frequency of <italic>MLH1</italic> promoter methylation was 14.0% (95% CI: 10.2–19.0%) in 353<italic> KRAS</italic>-mutated and 21.8% (95% CI: 13.2–33.8%) in 570 wild-type CRC, in three studies <xref ref-type="bibr" rid="pone.0059064-Kumar1">[15]</xref>, <xref ref-type="bibr" rid="pone.0059064-deVogel1">[21]</xref>, <xref ref-type="bibr" rid="pone.0059064-Iacopetta1">[22]</xref> (pooled OR = 0.476; 95% CI: 0.322–0.703; <italic>P</italic>&lt;0.001; <italic>I<sup>2</sup></italic> = 49.293%) (<xref ref-type="table" rid="pone-0059064-t002">Table 2</xref> and <xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>). Moreover, a statistically significant association was observed between <italic>MLH1</italic> promoter methylation and <italic>KRAS</italic> mutation in MSI CRC (OR = 0.340; 95% CI: 0.167–0.693; <italic>P = </italic>0.003; <italic>I<sup>2</sup></italic> = 0.000%) (<xref ref-type="table" rid="pone-0059064-t003">Table 3</xref>).</p>
      </sec>
      <sec id="s3k">
        <title>Publication Bias</title>
        <p>For the frequency of <italic>MLH1</italic> promoter methylation in MSI CRC and MSI-H CRC, the funnel plot seemed asymmetry (<xref ref-type="supplementary-material" rid="pone.0059064.s002">Figure S2 A and B</xref>). Funnel plot for the association between <italic>MLH1</italic> promoter methylation and tumor location (proximal vs. distal) also seemed asymmetry (<xref ref-type="supplementary-material" rid="pone.0059064.s003">Figure S3</xref>). Begg’s rank correlation and Egger’s regression methods further supported the significant publication bias. With the trim and fill method, the adjusted frequency of <italic>MLH1</italic> promoter methylation decreased from 55.8% to 36.7% in MSI CRC and from 62.6% to 53.5% in MSI-H CRC. The pooled OR for the association between <italic>MLH1</italic> promoter methylation and tumor location decreased from 3.804 (95% CI: 2.715–5.329) to 3.172 (95% CI: 2.323–4.331).</p>
      </sec>
    </sec>
    <sec id="s4">
      <title>Discussion</title>
      <p>Our meta-analysis suggested that the frequency of <italic>MLH1</italic> promoter methylation in total CRC was 20.3%. They were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively; significant associations were observed between <italic>MLH1</italic> promoter methylation and gender, tumor location, tumor differentiation, MSI, <italic>MLH1</italic> protein expression, and <italic>BRAF</italic> mutation.</p>
      <p>The pooled <italic>MLH1</italic> promoter methylation frequencies were 16.4% and 20.5% in 4 population-based studies and 16 hospital-based studies (One study <xref ref-type="bibr" rid="pone.0059064-Poynter1">[53]</xref> included 1061 population-based and 172 hospital-based CRC). In total CRC, the frequency of the <italic>MLH1</italic> promoter methylation between hospital-based and population-based studies was not significantly different (<italic>P</italic> = 0.279) (<xref ref-type="table" rid="pone-0059064-t001">Table 1</xref>).</p>
      <p>A, B, C and D regions in the <italic>MLH1</italic> promoter were commonly tested for methylation. However, only one study tested the <italic>MLH1</italic> promoter methylation in “A” region <xref ref-type="bibr" rid="pone.0059064-Strazzullo1">[69]</xref>, three studies tested the <italic>MLH1</italic> promoter methylation in “C” region <xref ref-type="bibr" rid="pone.0059064-Gay1">[56]</xref>, <xref ref-type="bibr" rid="pone.0059064-Grady1">[57]</xref>, <xref ref-type="bibr" rid="pone.0059064-Mirchev1">[70]</xref>, other 15 studies did not provide the specific A, B, C or D regions in total CRC. The <italic>MLH1</italic> promoter methylation frequency in “A” region (66.9%) was significantly higher than in “C” region in CRC (26.4%; <italic>P</italic> = 0.001) (<xref ref-type="supplementary-material" rid="pone.0059064.s004">Table S1</xref>). It may be due to the variation of methylation status in different regions of the <italic>MLH1</italic> promoter.</p>
      <p>The <italic>MLH1</italic> promoter methylation was detected in total of 12 studies with 968 MSI-H CRC with a frequency of 62.6%. After the adjustment by trim and fill method, the pooled frequency decreased to 53.5%. The pooled <italic>MLH1</italic> promoter methylation in 249 sporadic MSI-H CRC was 73.6%, significantly higher than in 95 LS MSI-H CRC (15.3%). The following may explain our results: in sporadic CRC, MSI-H was mainly caused by <italic>MLH1</italic> promoter methylation <xref ref-type="bibr" rid="pone.0059064-Cunningham1">[13]</xref>, <xref ref-type="bibr" rid="pone.0059064-Raedle1">[71]</xref>; whereas, in LS CRC, MSI-H was mainly caused by MMR inactivation because of germline mutation <xref ref-type="bibr" rid="pone.0059064-Peltomaki1">[72]</xref>.</p>
      <p>In sporadic CRC, our meta-analysis indicated that the <italic>MLH1</italic> promoter methylation frequency in 308 CRC with <italic>MLH1</italic> protein expression (9.8%), which was lower than in 156 CRC without <italic>MLH1</italic> protein expression (69.8%, <italic>P</italic>&lt;0.001). In CRC with loss of <italic>MLH1</italic> protein expression, the <italic>MLH1</italic> promoter methylation was significantly higher in sporadic CRC (69.8%) than in LS CRC (37.8%, <italic>P = </italic>0.026). In sporadic MSI-H CRC with loss of <italic>MLH1</italic> protein, the <italic>MLH1</italic> promoter methylation frequency was 86.3%. <italic>MLH1</italic> promoter methylation could explain more fraction of <italic>MLH1</italic> gene silencing in sporadic CRC than that in LS CRC. In this systematic review and meta-analysis, we can see that the highest frequency of <italic>MLH1</italic> promoter methylation was in MSI-H CRC with loss of <italic>MLH1</italic> protein, the following in sporadic CRC without <italic>MLH1</italic> protein expression, and the lowest in the sporadic CRC with <italic>MLH1</italic> protein expression.</p>
      <p>The frequency of <italic>MLH1</italic> promoter methylation in <italic>BRAF</italic> mutated total CRC was 53.2%, significantly higher than in <italic>BRAF</italic> wild type total CRC 13.7% (<italic>P = </italic>0.001). In contrast, the <italic>MLH1</italic> promoter methylation frequency in <italic>KRAS</italic> mutated total CRC (14.0%) was significantly lower than in <italic>KRAS</italic> wild type total CRC (21.8%) (<italic>P</italic>&lt;0.001). The largest population-based study <xref ref-type="bibr" rid="pone.0059064-deVogel1">[21]</xref> observed similar results, the frequencies of <italic>MLH1</italic> promoter methylation were 46.8% (51/109) in <italic>BRAF</italic> mutated CRC and 17.4% (97/559) <italic>BRAF</italic> wild type CRC (<italic>P</italic>&lt;0.001); whereas, they were 15.5% (40/258) in <italic>KRAS</italic> mutated CRC and 26.2% (112/428) <italic>KRAS</italic> wild type CRC (<italic>P = </italic>0.001). In MSI CRC, similar results were also observed. The <italic>MLH1</italic> promoter methylation frequency in <italic>BRAF</italic> mutated MSI-H CRC (94.5%) was significantly higher than in <italic>BRAF</italic> wild MSI-H CRC (28.2%) (<italic>P</italic>&lt;0.001). Whereas, the <italic>MLH1</italic> promoter methylation frequency in <italic>KRAS</italic> mutated MSI CRC (25.9%) was significantly lower than in <italic>KRAS</italic> wild MSI CRC (50.4%) (<italic>P = </italic>0.003). The following may explain the results: colon tumors progress by distinct genes of the RAS/RAF/MAP kinase pathway, depending on the genetic/epigenetic event underlying MMR deficiency (mutation and loss induced by <italic>MLH1</italic> promoter methylation). MSI-H tumors with MMR gene mutations (hereditary and sporadic forms) my preferentially target <italic>KRAS</italic>, whereas, MSI-H tumors with <italic>MLH1</italic> promoter methylation may preferentially target the <italic>BRAF</italic> gene <xref ref-type="bibr" rid="pone.0059064-Oliveira1">[73]</xref>. In addition, the methylation of <italic>MGMT</italic> was associated with <italic>KRAS</italic> mutant CRC but not of <italic>BRAF</italic> mutant CRC could also support the results of our meta-analysis <xref ref-type="bibr" rid="pone.0059064-Nagasaka1">[20]</xref>.</p>
      <p>Our study suggested that the frequency of <italic>MLH1</italic> promoter methylation was higher in female, proximal tumor location, and poor differentiation. Study reported that MSI CRC had a very distinct clinicopathological phenotype, which was commonly mucinous, poorly differentiated, presenting at earlier Dukes’ stage, and in the proximal side of the colon <xref ref-type="bibr" rid="pone.0059064-Ward2">[74]</xref>. MSI CRC was also commonly female and older at diagnosis. Moreover, in sporadic CRC, MSI was mainly caused by <italic>MLH1</italic> promoter methylation. Therefore, MSI CRC and <italic>MLH1</italic> promoter methylation CRC may have similar clinicopathological phenotype. However, the underlying mechanisms need to be investigated.</p>
      <p>Heterogeneity persisted in our meta-analysis. The followings may explain the sources of heterogeneity. Firstly, <italic>MLH1</italic> promoter methylation was tested in different promoter regions. One study tested in “A” region; three studies tested in “C” region; other 15 studies did not supply specific regions tested. Additionally, various ages of the study subjects may also explain the heterogeneity. Genes of individual are progressively methylated with aging due to chromosomal instability <xref ref-type="bibr" rid="pone.0059064-Issa2">[75]</xref>. However, only three of 19 studies provided the information of age of study subjects <xref ref-type="bibr" rid="pone.0059064-Menigatti1">[16]</xref>, <xref ref-type="bibr" rid="pone.0059064-Lind1">[54]</xref>, <xref ref-type="bibr" rid="pone.0059064-Shi1">[55]</xref>.</p>
      <p>Although this meta-analysis provides some robust results, limitations also existed like all the meta-analysis. Firstly, dietary factors, smoking and drinking alcohol may affect the <italic>MLH1</italic> promoter methylation. Lack of these original data of the studies reviewed limited our further evaluation of their effect on <italic>MLH1</italic> promoter methylation <xref ref-type="bibr" rid="pone.0059064-Aguilera1">[76]</xref>, <xref ref-type="bibr" rid="pone.0059064-Mathers1">[77]</xref>, <xref ref-type="bibr" rid="pone.0059064-Garagnani1">[78]</xref>. Secondly, lacking of the original data limited our further evaluation of the interactions between the clinicopathological and molecular variables in CRC. Thirdly, the prevalence of <italic>MLH1</italic> promoter methylation in CRC may increase with aging. However, the majority of studies did not provide this information, which limited our further evaluate their effect on <italic>MLH1</italic> promoter methylation.</p>
      <p>In summary, this systematic review and meta-analysis yield some conclusions: the <italic>MLH1</italic> methylation in total CRC was 20.3%; they were 18.7% in sporadic CRC and 16.4% in LS CRC, respectively; <italic>MLH1</italic> promoter methylation may be significantly associated with gender, tumor location, tumor differentiation, MSI, <italic>MLH1</italic> protein expression, and <italic>BRAF</italic> mutation.</p>
    </sec>
    <sec id="s5">
      <title>Supporting Information</title>
      <supplementary-material id="pone.0059064.s001" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0059064.s001" position="float" xlink:type="simple">
        <label>Figure S1</label>
        <caption>
          <p>
            <bold>Forest figure for association of </bold>
            <bold>
              <italic>MLHI</italic>
            </bold>
            <bold> promoter methylation and MSI status in CRC tumors (MSI vs. MSS).</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0059064.s002" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0059064.s002" position="float" xlink:type="simple">
        <label>Figure S2</label>
        <caption>
          <p>
            <bold>Funnel plot of the log (event rate) versus its standard error, for the frequency of </bold>
            <bold>
              <italic>MLH1</italic>
            </bold>
            <bold> promoter methylation in CRC tumors: (A) MSI and (B) MSI-H.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0059064.s003" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0059064.s003" position="float" xlink:type="simple">
        <label>Figure S3</label>
        <caption>
          <p>
            <bold>Funnel plot of the log odds ratio versus its standard error, for the frequency of </bold>
            <bold>
              <italic>MLH1</italic>
            </bold>
            <bold> promoter methylation in CRC tumors: Proximal vs. Distal.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0059064.s004" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0059064.s004" position="float" xlink:type="simple">
        <label>Table S1</label>
        <caption>
          <p>
            <bold>Pooled frequency of </bold>
            <bold>
              <italic>MLH1</italic>
            </bold>
            <bold> promoter methylation in colorectal cancer patients with other subgroup analysis.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0059064.s005" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0059064.s005" position="float" xlink:type="simple">
        <label>Text S1</label>
        <caption>
          <p>
            <bold>PRISMA Checklist.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
      <supplementary-material id="pone.0059064.s006" mimetype="application/msword" xlink:href="info:doi/10.1371/journal.pone.0059064.s006" position="float" xlink:type="simple">
        <label>Text S2</label>
        <caption>
          <p>
            <bold>Review protocol.</bold>
          </p>
          <p>(DOC)</p>
        </caption>
      </supplementary-material>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="pone.0059064-GLOBOCAN1">
        <label>1</label>
        <mixed-citation publication-type="other" xlink:type="simple">GLOBOCAN 2008 website. Cancer Fact Sheet. International Agency for Research on Cancer: World Health Organization. Available: <ext-link ext-link-type="uri" xlink:href="http://globocan.iarc.fr/factsheets/cancers/colorectal.asp" xlink:type="simple">http://globocan.iarc.fr/factsheets/cancers/colorectal.asp</ext-link>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Lengauer1">
        <label>2</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lengauer</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Kinzler</surname><given-names>KW</given-names></name>, <name name-style="western"><surname>Vogelstein</surname><given-names>B</given-names></name> (<year>1997</year>) <article-title>Genetic instability in colorectal cancers</article-title>. <source>Nature</source> <volume>386</volume>: <fpage>623</fpage>–<lpage>627</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Thibodeau1">
        <label>3</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Thibodeau</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Bren</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schaid</surname><given-names>D</given-names></name> (<year>1993</year>) <article-title>Microsatellite instability in cancer of the proximal colon</article-title>. <source>Science</source> <volume>260</volume>: <fpage>816</fpage>–<lpage>819</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Ionov1">
        <label>4</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ionov</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Peinado</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Malkhosyan</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Shibata</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Perucho</surname><given-names>M</given-names></name> (<year>1993</year>) <article-title>Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis</article-title>. <source>Nature</source> <volume>363</volume>: <fpage>558</fpage>–<lpage>561</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Aaltonen1">
        <label>5</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aaltonen</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Peltomaki</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Leach</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Sistonen</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Pylkkanen</surname><given-names>L</given-names></name>, <etal>et al</etal>. (<year>1993</year>) <article-title>Clues to the pathogenesis of familial colorectal cancer</article-title>. <source>Science</source> <volume>260</volume>: <fpage>812</fpage>–<lpage>816</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Tannergard1">
        <label>6</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Tannergard</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Liu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Weger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Nordenskjold</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Lindblom</surname><given-names>A</given-names></name> (<year>1997</year>) <article-title>Tumorigenesis in colorectal tumors from patients with hereditary non-polyposis colorectal cancer</article-title>. <source>Hum Genet</source> <volume>101</volume>: <fpage>51</fpage>–<lpage>55</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Jass1">
        <label>7</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Jass</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Walsh</surname><given-names>MD</given-names></name>, <name name-style="western"><surname>Barker</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Simms</surname><given-names>LA</given-names></name>, <name name-style="western"><surname>Young</surname><given-names>J</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Distinction between familial and sporadic forms of colorectal cancer showing DNA microsatellite instability</article-title>. <source>Eur J Cancer</source> <volume>38</volume>: <fpage>858</fpage>–<lpage>866</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Kane1">
        <label>8</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kane</surname><given-names>MF</given-names></name>, <name name-style="western"><surname>Loda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Gaida</surname><given-names>GM</given-names></name>, <name name-style="western"><surname>Lipman</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Mishra</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines</article-title>. <source>Cancer Res</source> <volume>57</volume>: <fpage>808</fpage>–<lpage>811</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Bird1">
        <label>9</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bird</surname><given-names>A</given-names></name> (<year>1992</year>) <article-title>The essentials of DNA methylation</article-title>. <source>Cell</source> <volume>70</volume>: <fpage>5</fpage>–<lpage>8</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Kondo1">
        <label>10</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kondo</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Issa</surname><given-names>JP</given-names></name> (<year>2004</year>) <article-title>Epigenetic changes in colorectal cancer</article-title>. <source>Cancer Metastasis Rev</source> <volume>23</volume>: <fpage>29</fpage>–<lpage>39</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Issa1">
        <label>11</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Issa</surname><given-names>JP</given-names></name> (<year>2004</year>) <article-title>CpG island methylator phenotype in cancer</article-title>. <source>Nat Rev Cancer</source> <volume>4</volume>: <fpage>988</fpage>–<lpage>993</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Herman1">
        <label>12</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Herman</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Umar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Polyak</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Graff</surname><given-names>JR</given-names></name>, <name name-style="western"><surname>Ahuja</surname><given-names>N</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>95</volume>: <fpage>6870</fpage>–<lpage>6875</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Cunningham1">
        <label>13</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cunningham</surname><given-names>JM</given-names></name>, <name name-style="western"><surname>Christensen</surname><given-names>ER</given-names></name>, <name name-style="western"><surname>Tester</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>CY</given-names></name>, <name name-style="western"><surname>Roche</surname><given-names>PC</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>Hypermethylation of the hMLH1 promoter in colon cancer with microsatellite instability</article-title>. <source>Cancer Res</source> <volume>58</volume>: <fpage>3455</fpage>–<lpage>3460</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Belshaw1">
        <label>14</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Belshaw</surname><given-names>NJ</given-names></name>, <name name-style="western"><surname>Elliott</surname><given-names>GO</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>EA</given-names></name>, <name name-style="western"><surname>Bradburn</surname><given-names>DM</given-names></name>, <name name-style="western"><surname>Mills</surname><given-names>SJ</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>13</volume>: <fpage>1495</fpage>–<lpage>1501</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Kumar1">
        <label>15</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kumar</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Brim</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Giardiello</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Smoot</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Nouraie</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Distinct BRAF (V600E) and KRAS mutations in high microsatellite instability sporadic colorectal cancer in African Americans</article-title>. <source>Clin Cancer Res</source> <volume>15</volume>: <fpage>1155</fpage>–<lpage>1161</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Menigatti1">
        <label>16</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Menigatti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Di Gregorio</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Borghi</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Sala</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Scarselli</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Methylation pattern of different regions of the MLH1 promoter and silencing of gene expression in hereditary and sporadic colorectal cancer</article-title>. <source>Genes Chromosomes Cancer</source> <volume>31</volume>: <fpage>357</fpage>–<lpage>361</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Park1">
        <label>17</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Park</surname><given-names>IJ</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>HC</given-names></name>, <name name-style="western"><surname>Yoon</surname><given-names>YS</given-names></name>, <name name-style="western"><surname>Yu</surname><given-names>CS</given-names></name>, <name name-style="western"><surname>Jang</surname><given-names>SJ</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Clinicopathological characteristics of colorectal cancer with family history: an evaluation of family history as a predictive factor for microsatellite instability</article-title>. <source>J Korean Med Sci</source> <volume>22</volume> Suppl: S91–97</mixed-citation>
      </ref>
      <ref id="pone.0059064-Peyssonnaux1">
        <label>18</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peyssonnaux</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Eychene</surname><given-names>A</given-names></name> (<year>2001</year>) <article-title>The Raf/MEK/ERK pathway: new concepts of activation</article-title>. <source>Biol Cell</source> <volume>93</volume>: <fpage>53</fpage>–<lpage>62</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Bettstetter1">
        <label>19</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Bettstetter</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Dechant</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Ruemmele</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Grabowski</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Keller</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2007</year>) <article-title>Distinction of hereditary nonpolyposis colorectal cancer and sporadic microsatellite-unstable colorectal cancer through quantification of MLH1 methylation by real-time PCR</article-title>. <source>Clin Cancer Res</source> <volume>13</volume>: <fpage>3221</fpage>–<lpage>3228</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Nagasaka1">
        <label>20</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nagasaka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sasamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Notohara</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Cullings</surname><given-names>HM</given-names></name>, <name name-style="western"><surname>Takeda</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Colorectal cancer with mutation in BRAF, KRAS, and wild-type with respect to both oncogenes showing different patterns of DNA methylation</article-title>. <source>J Clin Oncol</source> <volume>22</volume>: <fpage>4584</fpage>–<lpage>4594</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-deVogel1">
        <label>21</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>de Vogel</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Weijenberg</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>JG</given-names></name>, <name name-style="western"><surname>Wouters</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>de Goeij</surname><given-names>AF</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>MGMT and MLH1 promoter methylation versus APC, KRAS and BRAF gene mutations in colorectal cancer: indications for distinct pathways and sequence of events</article-title>. <source>Ann Oncol</source> <volume>20</volume>: <fpage>1216</fpage>–<lpage>1222</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Iacopetta1">
        <label>22</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Iacopetta</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Grieu</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>W</given-names></name>, <name name-style="western"><surname>Ruszkiewicz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Caruso</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>APC gene methylation is inversely correlated with features of the CpG island methylator phenotype in colorectal cancer</article-title>. <source>Int J Cancer</source> <volume>119</volume>: <fpage>2272</fpage>–<lpage>2278</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Deng1">
        <label>23</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Bell</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Crawley</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Gum</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Terdiman</surname><given-names>JP</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>BRAF mutation is frequently present in sporadic colorectal cancer with methylated hMLH1, but not in hereditary nonpolyposis colorectal cancer</article-title>. <source>Clin Cancer Res</source> <volume>10</volume>: <fpage>191</fpage>–<lpage>195</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Ahlquist1">
        <label>24</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ahlquist</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Lind</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Costa</surname><given-names>VL</given-names></name>, <name name-style="western"><surname>Meling</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Vatn</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Gene methylation profiles of normal mucosa, and benign and malignant colorectal tumors identify early onset markers</article-title>. <source>Mol Cancer</source> <volume>7</volume>: <fpage>94</fpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Nakagawa1">
        <label>25</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nakagawa</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Nuovo</surname><given-names>GJ</given-names></name>, <name name-style="western"><surname>Zervos</surname><given-names>EE</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>EW</given-names><suffix>Jr</suffix></name>, <name name-style="western"><surname>Salovaara</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Age-related hypermethylation of the 5′ region of MLH1 in normal colonic mucosa is associated with microsatellite-unstable colorectal cancer development</article-title>. <source>Cancer Res</source> <volume>61</volume>: <fpage>6991</fpage>–<lpage>6995</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Menigatti2">
        <label>26</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Menigatti</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Truninger</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Gebbers</surname><given-names>JO</given-names></name>, <name name-style="western"><surname>Marbet</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Marra</surname><given-names>G</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Normal colorectal mucosa exhibits sex- and segment-specific susceptibility to DNA methylation at the hMLH1 and MGMT promoters</article-title>. <source>Oncogene</source> <volume>28</volume>: <fpage>899</fpage>–<lpage>909</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Wallner1">
        <label>27</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wallner</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Herbst</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Behrens</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Crispin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Stieber</surname><given-names>P</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Methylation of serum DNA is an independent prognostic marker in colorectal cancer</article-title>. <source>Clin Cancer Res</source> <volume>12</volume>: <fpage>7347</fpage>–<lpage>7352</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Leung1">
        <label>28</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Leung</surname><given-names>WK</given-names></name>, <name name-style="western"><surname>To</surname><given-names>KF</given-names></name>, <name name-style="western"><surname>Man</surname><given-names>EP</given-names></name>, <name name-style="western"><surname>Chan</surname><given-names>MW</given-names></name>, <name name-style="western"><surname>Bai</surname><given-names>AH</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Quantitative detection of promoter hypermethylation in multiple genes in the serum of patients with colorectal cancer</article-title>. <source>Am J Gastroenterol</source> <volume>100</volume>: <fpage>2274</fpage>–<lpage>2279</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Zhou1">
        <label>29</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Zhou</surname><given-names>HH</given-names></name>, <name name-style="western"><surname>Yan</surname><given-names>SY</given-names></name>, <name name-style="western"><surname>Zhou</surname><given-names>XY</given-names></name>, <name name-style="western"><surname>Du</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>TM</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>MLH1 promoter germline-methylation in selected probands of Chinese hereditary non-polyposis colorectal cancer families</article-title>. <source>World J Gastroenterol</source> <volume>14</volume>: <fpage>7329</fpage>–<lpage>7334</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Miyakura1">
        <label>30</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Miyakura</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Sugano</surname><given-names>K</given-names></name>, <name name-style="western"><surname>Akasu</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Yoshida</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Maekawa</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Extensive but hemiallelic methylation of the hMLH1 promoter region in early-onset sporadic colon cancers with microsatellite instability</article-title>. <source>Clin Gastroenterol Hepatol</source> <volume>2</volume>: <fpage>147</fpage>–<lpage>156</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Gazzoli1">
        <label>31</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gazzoli</surname><given-names>I</given-names></name>, <name name-style="western"><surname>Loda</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Garber</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Syngal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Kolodner</surname><given-names>RD</given-names></name> (<year>2002</year>) <article-title>A hereditary nonpolyposis colorectal carcinoma case associated with hypermethylation of the MLH1 gene in normal tissue and loss of heterozygosity of the unmethylated allele in the resulting microsatellite instability-high tumor</article-title>. <source>Cancer Res</source> <volume>62</volume>: <fpage>3925</fpage>–<lpage>3928</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Lawes1">
        <label>32</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lawes</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Pearson</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Sengupta</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Boulos</surname><given-names>PB</given-names></name> (<year>2005</year>) <article-title>The role of MLH1, MSH2 and MSH6 in the development of multiple colorectal cancers</article-title>. <source>Br J Cancer</source> <volume>93</volume>: <fpage>472</fpage>–<lpage>477</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Dykes1">
        <label>33</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dykes</surname><given-names>SL</given-names></name>, <name name-style="western"><surname>Qui</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Rothenberger</surname><given-names>DA</given-names></name>, <name name-style="western"><surname>Garcia-Aguilar</surname><given-names>J</given-names></name> (<year>2003</year>) <article-title>Evidence of a preferred molecular pathway in patients with synchronous colorectal cancer</article-title>. <source>Cancer</source> <volume>98</volume>: <fpage>48</fpage>–<lpage>54</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Velayos1">
        <label>34</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Velayos</surname><given-names>FS</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Dykes</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Yiu</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>The mechanism of microsatellite instability is different in synchronous and metachronous colorectal cancer</article-title>. <source>J Gastrointest Surg</source> <volume>9</volume>: <fpage>329</fpage>–<lpage>335</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Vasen1">
        <label>35</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasen</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Mecklin</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Khan</surname><given-names>PM</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>HT</given-names></name> (<year>1991</year>) <article-title>The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)</article-title>. <source>Dis Colon Rectum</source> <volume>34</volume>: <fpage>424</fpage>–<lpage>425</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Vasen2">
        <label>36</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vasen</surname><given-names>HF</given-names></name>, <name name-style="western"><surname>Watson</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Mecklin</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Lynch</surname><given-names>HT</given-names></name> (<year>1999</year>) <article-title>New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC</article-title>. <source>Gastroenterology</source> <volume>116</volume>: <fpage>1453</fpage>–<lpage>1456</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-RodriguezBigas1">
        <label>37</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Rodriguez-Bigas</surname><given-names>MA</given-names></name>, <name name-style="western"><surname>Boland</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Henson</surname><given-names>DE</given-names></name>, <name name-style="western"><surname>Jass</surname><given-names>JR</given-names></name>, <etal>et al</etal>. (<year>1997</year>) <article-title>A National Cancer Institute Workshop on Hereditary Nonpolyposis Colorectal Cancer Syndrome: meeting highlights and Bethesda guidelines</article-title>. <source>J Natl Cancer Inst</source> <volume>89</volume>: <fpage>1758</fpage>–<lpage>1762</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Umar1">
        <label>38</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Umar</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Boland</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Terdiman</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Syngal</surname><given-names>S</given-names></name>, <name name-style="western"><surname>de la Chapelle</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability</article-title>. <source>J Natl Cancer Inst</source> <volume>96</volume>: <fpage>261</fpage>–<lpage>268</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Hampel1">
        <label>39</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Hampel</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Frankel</surname><given-names>WL</given-names></name>, <name name-style="western"><surname>Martin</surname><given-names>E</given-names></name>, <name name-style="western"><surname>Arnold</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Khanduja</surname><given-names>K</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)</article-title>. <source>N Engl J Med</source> <volume>352</volume>: <fpage>1851</fpage>–<lpage>1860</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Ward1">
        <label>40</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ward</surname><given-names>RL</given-names></name>, <name name-style="western"><surname>Turner</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Williams</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Pekarsky</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Packham</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Routine testing for mismatch repair deficiency in sporadic colorectal cancer is justified</article-title>. <source>J Pathol</source> <volume>207</volume>: <fpage>377</fpage>–<lpage>384</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Sobin1">
        <label>41</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Sobin</surname><given-names>LH</given-names></name>, <name name-style="western"><surname>Fleming</surname><given-names>ID</given-names></name> (<year>1997</year>) <article-title>TNM Classification of Malignant Tumors, fifth edition (1997). Union Internationale Contre le Cancer and the American Joint Committee on Cancer</article-title>. <source>Cancer</source> <volume>80</volume>: <fpage>1803</fpage>–<lpage>1804</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Deng2">
        <label>42</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Deng</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Chen</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Hong</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Chae</surname><given-names>HS</given-names></name>, <name name-style="western"><surname>Kim</surname><given-names>YS</given-names></name> (<year>1999</year>) <article-title>Methylation of CpG in a small region of the hMLH1 promoter invariably correlates with the absence of gene expression</article-title>. <source>Cancer Res</source> <volume>59</volume>: <fpage>2029</fpage>–<lpage>2033</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Boland1">
        <label>43</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Boland</surname><given-names>CR</given-names></name>, <name name-style="western"><surname>Thibodeau</surname><given-names>SN</given-names></name>, <name name-style="western"><surname>Hamilton</surname><given-names>SR</given-names></name>, <name name-style="western"><surname>Sidransky</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Eshleman</surname><given-names>JR</given-names></name>, <etal>et al</etal>. (<year>1998</year>) <article-title>A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer</article-title>. <source>Cancer Res</source> <volume>58</volume>: <fpage>5248</fpage>–<lpage>5257</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-DerSimonian1">
        <label>44</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>DerSimonian</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Laird</surname><given-names>N</given-names></name> (<year>1986</year>) <article-title>Meta-analysis in clinical trials</article-title>. <source>Control Clin Trials</source> <volume>7</volume>: <fpage>177</fpage>–<lpage>188</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Higgins1">
        <label>45</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Higgins</surname><given-names>JP</given-names></name>, <name name-style="western"><surname>Thompson</surname><given-names>SG</given-names></name>, <name name-style="western"><surname>Deeks</surname><given-names>JJ</given-names></name>, <name name-style="western"><surname>Altman</surname><given-names>DG</given-names></name> (<year>2003</year>) <article-title>Measuring inconsistency in meta-analyses</article-title>. <source>BMJ</source> <volume>327</volume>: <fpage>557</fpage>–<lpage>560</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-DerSimonian2">
        <label>46</label>
        <mixed-citation publication-type="other" xlink:type="simple">DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15: 1237–1248; discussion 1249–1252.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Begg1">
        <label>47</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Begg</surname><given-names>CB</given-names></name>, <name name-style="western"><surname>Mazumdar</surname><given-names>M</given-names></name> (<year>1994</year>) <article-title>Operating characteristics of a rank correlation test for publication bias</article-title>. <source>Biometrics</source> <volume>50</volume>: <fpage>1088</fpage>–<lpage>1101</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Egger1">
        <label>48</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Egger</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Davey Smith</surname><given-names>G</given-names></name>, <name name-style="western"><surname>Schneider</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Minder</surname><given-names>C</given-names></name> (<year>1997</year>) <article-title>Bias in meta-analysis detected by a simple, graphical test</article-title>. <source>BMJ</source> <volume>315</volume>: <fpage>629</fpage>–<lpage>634</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Duval1">
        <label>49</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Duval</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Tweedie</surname><given-names>R</given-names></name> (<year>2000</year>) <article-title>Trim and fill: A simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis</article-title>. <source>Biometrics</source> <volume>56</volume>: <fpage>455</fpage>–<lpage>463</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Yamamoto1">
        <label>50</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yamamoto</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Min</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Itoh</surname><given-names>F</given-names></name>, <name name-style="western"><surname>Imsumran</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Horiuchi</surname><given-names>S</given-names></name>, <etal>et al</etal>. (<year>2002</year>) <article-title>Differential involvement of the hypermethylator phenotype in hereditary and sporadic colorectal cancers with high-frequency microsatellite instability</article-title>. <source>Genes Chromosomes Cancer</source> <volume>33</volume>: <fpage>322</fpage>–<lpage>325</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Julie1">
        <label>51</label>
        <mixed-citation publication-type="other" xlink:type="simple">Julie C, Tresallet C, Brouquet A, Vallot C, Zimmermann U, <etal>et al</etal>.. (2008) Identification in daily practice of patients with Lynch syndrome (hereditary nonpolyposis colorectal cancer): revised Bethesda guidelines-based approach versus molecular screening. Am J Gastroenterol 103: 2825–2835; quiz 2836.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Potocnik1">
        <label>52</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Potocnik</surname><given-names>U</given-names></name>, <name name-style="western"><surname>Glavac</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Golouh</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ravnik-Glavac</surname><given-names>M</given-names></name> (<year>2001</year>) <article-title>Causes of microsatellite instability in colorectal tumors: implications for hereditary non-polyposis colorectal cancer screening</article-title>. <source>Cancer Genet Cytogenet</source> <volume>126</volume>: <fpage>85</fpage>–<lpage>96</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Poynter1">
        <label>53</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Poynter</surname><given-names>JN</given-names></name>, <name name-style="western"><surname>Siegmund</surname><given-names>KD</given-names></name>, <name name-style="western"><surname>Weisenberger</surname><given-names>DJ</given-names></name>, <name name-style="western"><surname>Long</surname><given-names>TI</given-names></name>, <name name-style="western"><surname>Thibodeau</surname><given-names>SN</given-names></name>, <etal>et al</etal>. (<year>2008</year>) <article-title>Molecular characterization of MSI-H colorectal cancer by MLHI promoter methylation, immunohistochemistry, and mismatch repair germline mutation screening</article-title>. <source>Cancer Epidemiol Biomarkers Prev</source> <volume>17</volume>: <fpage>3208</fpage>–<lpage>3215</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Lind1">
        <label>54</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lind</surname><given-names>GE</given-names></name>, <name name-style="western"><surname>Thorstensen</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Lovig</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Meling</surname><given-names>GI</given-names></name>, <name name-style="western"><surname>Hamelin</surname><given-names>R</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines</article-title>. <source>Mol Cancer</source> <volume>3</volume>: <fpage>28</fpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Shi1">
        <label>55</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name>, <name name-style="western"><surname>Li</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Zhao</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lv</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Xu</surname><given-names>G</given-names></name> (<year>2006</year>) <article-title>Methylation analysis of hMLH1 gene promoter by a bisulfite-sensitive single-strand conformation polymorphism-capillary electrophoresis method</article-title>. <source>Biomed Chromatogr</source> <volume>20</volume>: <fpage>815</fpage>–<lpage>820</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Gay1">
        <label>56</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gay</surname><given-names>LJ</given-names></name>, <name name-style="western"><surname>Arends</surname><given-names>MJ</given-names></name>, <name name-style="western"><surname>Mitrou</surname><given-names>PN</given-names></name>, <name name-style="western"><surname>Bowman</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Ibrahim</surname><given-names>AE</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>MLH1 promoter methylation, diet, and lifestyle factors in mismatch repair deficient colorectal cancer patients from EPIC-Norfolk</article-title>. <source>Nutr Cancer</source> <volume>63</volume>: <fpage>1000</fpage>–<lpage>1010</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Grady1">
        <label>57</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Grady</surname><given-names>WM</given-names></name>, <name name-style="western"><surname>Rajput</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Lutterbaugh</surname><given-names>JD</given-names></name>, <name name-style="western"><surname>Markowitz</surname><given-names>SD</given-names></name> (<year>2001</year>) <article-title>Detection of aberrantly methylated hMLH1 promoter DNA in the serum of patients with microsatellite unstable colon cancer</article-title>. <source>Cancer Res</source> <volume>61</volume>: <fpage>900</fpage>–<lpage>902</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Brandes1">
        <label>58</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Brandes</surname><given-names>JC</given-names></name>, <name name-style="western"><surname>van Engeland</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Wouters</surname><given-names>KA</given-names></name>, <name name-style="western"><surname>Weijenberg</surname><given-names>MP</given-names></name>, <name name-style="western"><surname>Herman</surname><given-names>JG</given-names></name> (<year>2005</year>) <article-title>CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype</article-title>. <source>Carcinogenesis</source> <volume>26</volume>: <fpage>1152</fpage>–<lpage>1156</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Anacleto1">
        <label>59</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Anacleto</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Leopoldino</surname><given-names>AM</given-names></name>, <name name-style="western"><surname>Rossi</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Soares</surname><given-names>FA</given-names></name>, <name name-style="western"><surname>Lopes</surname><given-names>A</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Colorectal cancer “methylator phenotype”: fact or artifact?</article-title> <source>Neoplasia</source> <volume>7</volume>: <fpage>331</fpage>–<lpage>335</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Samowitz1">
        <label>60</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Samowitz</surname><given-names>WS</given-names></name>, <name name-style="western"><surname>Albertsen</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Herrick</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Levin</surname><given-names>TR</given-names></name>, <name name-style="western"><surname>Sweeney</surname><given-names>C</given-names></name>, <etal>et al</etal>. (<year>2005</year>) <article-title>Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer</article-title>. <source>Gastroenterology</source> <volume>129</volume>: <fpage>837</fpage>–<lpage>845</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Shannon1">
        <label>61</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Shannon</surname><given-names>BA</given-names></name>, <name name-style="western"><surname>Iacopetta</surname><given-names>BJ</given-names></name> (<year>2001</year>) <article-title>Methylation of the hMLH1, p16, and MDR1 genes in colorectal carcinoma: associations with clinicopathological features</article-title>. <source>Cancer Lett</source> <volume>167</volume>: <fpage>91</fpage>–<lpage>97</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Kuismanen1">
        <label>62</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Kuismanen</surname><given-names>SA</given-names></name>, <name name-style="western"><surname>Holmberg</surname><given-names>MT</given-names></name>, <name name-style="western"><surname>Salovaara</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Schweizer</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Aaltonen</surname><given-names>LA</given-names></name>, <etal>et al</etal>. (<year>1999</year>) <article-title>Epigenetic phenotypes distinguish microsatellite-stable and -unstable colorectal cancers</article-title>. <source>Proc Natl Acad Sci U S A</source> <volume>96</volume>: <fpage>12661</fpage>–<lpage>12666</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Yiu1">
        <label>63</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Yiu</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>SH</given-names></name>, <name name-style="western"><surname>Garcia-Aguilar</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Mechanisms of microsatellite instability in colorectal cancer patients in different age groups</article-title>. <source>Dis Colon Rectum</source> <volume>48</volume>: <fpage>2061</fpage>–<lpage>2069</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Huang1">
        <label>64</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Huang</surname><given-names>Q</given-names></name>, <name name-style="western"><surname>Huang</surname><given-names>JF</given-names></name>, <name name-style="western"><surname>Zhang</surname><given-names>B</given-names></name>, <name name-style="western"><surname>Baum</surname><given-names>L</given-names></name>, <name name-style="western"><surname>Fu</surname><given-names>WL</given-names></name> (<year>2012</year>) <article-title>Methylation variable position profiles of hMLH1 promoter CpG islands in human sporadic colorectal carcinoma</article-title>. <source>Diagn Mol Pathol</source> <volume>21</volume>: <fpage>24</fpage>–<lpage>33</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Fox1">
        <label>65</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fox</surname><given-names>EJ</given-names></name>, <name name-style="western"><surname>Leahy</surname><given-names>DT</given-names></name>, <name name-style="western"><surname>Geraghty</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Mulcahy</surname><given-names>HE</given-names></name>, <name name-style="western"><surname>Fennelly</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2006</year>) <article-title>Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer</article-title>. <source>J Mol Diagn</source> <volume>8</volume>: <fpage>68</fpage>–<lpage>75</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Vilkin1">
        <label>66</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Vilkin</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Niv</surname><given-names>Y</given-names></name>, <name name-style="western"><surname>Nagasaka</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Morgenstern</surname><given-names>S</given-names></name>, <name name-style="western"><surname>Levi</surname><given-names>Z</given-names></name>, <etal>et al</etal>. (<year>2009</year>) <article-title>Microsatellite instability, MLH1 promoter methylation, and BRAF mutation analysis in sporadic colorectal cancers of different ethnic groups in Israel</article-title>. <source>Cancer</source> <volume>115</volume>: <fpage>760</fpage>–<lpage>769</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Lee1">
        <label>67</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lee</surname><given-names>KH</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>JS</given-names></name>, <name name-style="western"><surname>Nam</surname><given-names>JH</given-names></name>, <name name-style="western"><surname>Choi</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Lee</surname><given-names>MC</given-names></name>, <etal>et al</etal>. (<year>2011</year>) <article-title>Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence</article-title>. <source>Langenbecks Arch Surg</source> <volume>396</volume>: <fpage>1017</fpage>–<lpage>1026</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Arnold1">
        <label>68</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Arnold</surname><given-names>CN</given-names></name>, <name name-style="western"><surname>Goel</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Compton</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Marcus</surname><given-names>V</given-names></name>, <name name-style="western"><surname>Niedzwiecki</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Evaluation of microsatellite instability, hMLH1 expression and hMLH1 promoter hypermethylation in defining the MSI phenotype of colorectal cancer</article-title>. <source>Cancer Biol Ther</source> <volume>3</volume>: <fpage>73</fpage>–<lpage>78</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Strazzullo1">
        <label>69</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Strazzullo</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Cossu</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Baldinu</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Colombino</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Satta</surname><given-names>MP</given-names></name>, <etal>et al</etal>. (<year>2003</year>) <article-title>High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas</article-title>. <source>Cancer</source> <volume>98</volume>: <fpage>1540</fpage>–<lpage>1546</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Mirchev1">
        <label>70</label>
        <mixed-citation publication-type="other" xlink:type="simple">Mirchev M, Kotzev I, Kahl P, Büttner R, Angelova L, <etal>et al</etal>.. (2007) Epigenetic silencing of MLH1 and p16INK and their relation to certain clinicopathological features in patients with colorectal cancer. Journal of IMAB - Annual Proceeding (Scientific Papers): 95–96.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Raedle1">
        <label>71</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Raedle</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Trojan</surname><given-names>J</given-names></name>, <name name-style="western"><surname>Brieger</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Weber</surname><given-names>N</given-names></name>, <name name-style="western"><surname>Schafer</surname><given-names>D</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Bethesda guidelines: relation to microsatellite instability and MLH1 promoter methylation in patients with colorectal cancer</article-title>. <source>Ann Intern Med</source> <volume>135</volume>: <fpage>566</fpage>–<lpage>576</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Peltomaki1">
        <label>72</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Peltomaki</surname><given-names>P</given-names></name>, <name name-style="western"><surname>Vasen</surname><given-names>HF</given-names></name> (<year>1997</year>) <article-title>Mutations predisposing to hereditary nonpolyposis colorectal cancer: database and results of a collaborative study. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer</article-title>. <source>Gastroenterology</source> <volume>113</volume>: <fpage>1146</fpage>–<lpage>1158</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Oliveira1">
        <label>73</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Oliveira</surname><given-names>C</given-names></name>, <name name-style="western"><surname>Westra</surname><given-names>JL</given-names></name>, <name name-style="western"><surname>Arango</surname><given-names>D</given-names></name>, <name name-style="western"><surname>Ollikainen</surname><given-names>M</given-names></name>, <name name-style="western"><surname>Domingo</surname><given-names>E</given-names></name>, <etal>et al</etal>. (<year>2004</year>) <article-title>Distinct patterns of KRAS mutations in colorectal carcinomas according to germline mismatch repair defects and hMLH1 methylation status</article-title>. <source>Hum Mol Genet</source> <volume>13</volume>: <fpage>2303</fpage>–<lpage>2311</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Ward2">
        <label>74</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ward</surname><given-names>R</given-names></name>, <name name-style="western"><surname>Meagher</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Tomlinson</surname><given-names>I</given-names></name>, <name name-style="western"><surname>O’Connor</surname><given-names>T</given-names></name>, <name name-style="western"><surname>Norrie</surname><given-names>M</given-names></name>, <etal>et al</etal>. (<year>2001</year>) <article-title>Microsatellite instability and the clinicopathological features of sporadic colorectal cancer</article-title>. <source>Gut</source> <volume>48</volume>: <fpage>821</fpage>–<lpage>829</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Issa2">
        <label>75</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Issa</surname><given-names>JP</given-names></name> (<year>1999</year>) <article-title>Aging, DNA methylation and cancer</article-title>. <source>Crit Rev Oncol Hematol</source> <volume>32</volume>: <fpage>31</fpage>–<lpage>43</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Aguilera1">
        <label>76</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Aguilera</surname><given-names>O</given-names></name>, <name name-style="western"><surname>Fernandez</surname><given-names>AF</given-names></name>, <name name-style="western"><surname>Munoz</surname><given-names>A</given-names></name>, <name name-style="western"><surname>Fraga</surname><given-names>MF</given-names></name> (<year>2010</year>) <article-title>Epigenetics and environment: a complex relationship</article-title>. <source>J Appl Physiol</source> <volume>109</volume>: <fpage>243</fpage>–<lpage>251</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Mathers1">
        <label>77</label>
        <mixed-citation publication-type="journal" xlink:type="simple"><article-title>Mathers JC, Strathdee G, Relton CL Induction of epigenetic alterations by dietary and other environmental factors</article-title>. <source>Adv Genet</source> <volume>71</volume>: <fpage>3</fpage>–<lpage>39</lpage>.</mixed-citation>
      </ref>
      <ref id="pone.0059064-Garagnani1">
        <label>78</label>
        <mixed-citation publication-type="other" xlink:type="simple">Garagnani P, Pirazzini C, Franceschi C (2012) Colorectal Cancer Microenvironment: among Nutrition, Gut Microbiota, Inflammation and Epigenetics. Curr Pharm Des.</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>